 cisplatin fluorouracil chemotherapi long-term benefit advanc head neck cancer result singl institut patient head neck cancer cycl cisplatin continu infus fluorouracil induct chemotherapi subsequ local therapi surgeri patient resect diseas and/or radiotherapi cycl adjuv chemotherapi patient partial respons PR complet respons CR induct chemotherapi twenty-two patient clinic CR patient patient PR overal respons rate local therapi surgeri patient patient adjuv chemotherapi patient great dose reduct median follow-up month median surviv month confid interv month surviv patient aliv disease-fre time median time progress month patient progress head neck cancer progress second neoplasm patient medic event high incid second malign continu investig chemoprevent patient CR high respons rate cisplatin induct chemotherapi overal poor surviv data thorough reexamin frequent administr regimen commun